Mycori

Mycori develops a 100 percent natural mushroom-based leather alternative for industries that currently rely on animal leather.

Zurich, CH

Founded

2023

Competitive Landscape

Mycori competes in the emerging mycelium- and mushroom-based leather alternatives category, where the most visible named alternative is MycoWorks of California with its Reishi fine mycelium material, alongside firms such as MycoCycle pursuing related routes. Mycori's distinguishing claim is a patented, industrially controlled process that works with locally sourced mushroom fibers to produce a fully bio-based, biodegradable material with high reproducibility, which the 2025 Swiss Design Award Circular Design jury treated as distinct from mycelium- or plant-based alternatives.

For the same buyer — makers replacing animal leather — adjacent substitutes include plant-based and synthetic vegan leathers, so Mycori's trade-off is less scale and market presence than established international players, offset by a locally controlled, customizable production process. The decisive contest is therefore industrial reproducibility and customer access rather than material chemistry, where a young Swiss entrant must win pioneering brands before category leaders consolidate the market.

Source: designpreis.ch

Market Outlook

Mycori's position in mushroom-based leather alternatives is supported by a category in visible motion: as of September 2025 and 2026, industry reporting placed mushroom leather on a path of growing commercial adoption across fashion and materials, while competitors such as MycoWorks secured further demand and adjusted their business models in 2025-2026, a sign of both growing demand and a demanding commercial environment for young entrants.

For Mycori, the outlook therefore hinges on converting its patented process and 2025 Swiss Design Award recognition into industrial-scale customers; if leather-replacement demand keeps rising, its locally sourced, customizable fiber process could gain share in European design and fashion niches, while a consolidation of funding around larger international players would weaken that trajectory.

Risk Factors

Mycori's principal risks are concentration and scale: the venture has a single registered board member, founder Hans Peter "Ben" Weinberg, since its August 2023 registration, so execution depends on a very small leadership base. As of January 2025, its mushroom leather was publicly described by the founder as still at an early development stage, which leaves the company exposed to technical maturity risk on top of its commercial one.

A further risk is competitive exposure: better-funded international players dominate category news, so Mycori's mitigants are its registered trademark MYCORI (Swissreg, filed March 2024), its patent-protected process, and its positioning as a customization partner, which are facts, while the inference that these suffice against larger rivals remains an analyst judgment.